At Cell Constructs, we are committed to innovating new human keratin-based healthcare technologies in order to provide patients and their healthcare providers with leading-edge, globally-accessible wound care solutions. Our scientists are discovering new formulations and configurations of human keratin wound care technologies to optimize delivery and healing potential.
Our patient-centric research philosophy values results, integrity, and resourcefulness. Our integrated approach to product development incorporates medical, scientific, regulatory, and economic expertise to ensure we deliver highly effective and economically viable solutions to clinical practices in regions around the world.
What are the next frontiers in wound care advancements?
These are a handful of the questions our R&D team is actively pursuing as we seek to help patients and physicians across the world in their path to healing.
ProgenaMatrix™ is a medical device cleared by the US FDA for the treatment of dry and exuding partial and full thickness wounds.